Even when given the same drug, some patients respond well while others show little or no response. This is particularly true of immunotherapy. A research team at POSTECH (Pohang University of Science and Technology) has developed an artificial intelligence (AI) technology that can predict, in advance, which patients are likely to benefit from treatment.